Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
1.215
+0.025 (2.10%)
Nov 21, 2024, 11:44 AM EST - Market open
Biodesix Market Cap
Biodesix has a market cap or net worth of $176.74 million as of November 21, 2024. Its market cap has increased by 31.99% in one year.
Market Cap
176.74M
Enterprise Value
204.20M
1-Year Change
31.99%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $176.74M, a decrease of -62.60%. That is a compound annual growth rate of -21.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 173.11M | 3.98% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 13.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 181.11M |
| Accuray | 180.51M |
| Heron Therapeutics | 179.47M |
| Verastem | 178.69M |
| BrainsWay | 177.54M |
| scPharmaceuticals | 177.14M |
| Kyverna Therapeutics | 177.00M |
| Nkarta | 175.36M |